Search by Drug Name or NDC
NDC 17856-0799-05 MYLICON 20 mg/.3mL Details
MYLICON 20 mg/.3mL
MYLICON is a ORAL SUSPENSION in the HUMAN OTC DRUG category. It is labeled and distributed by ATLANTIC BIOLOGICALS CORP.. The primary component is DIMETHICONE.
Product Information
NDC | 17856-0799 |
---|---|
Product ID | 17856-0799_eb3941c1-96e7-4bf4-9baf-d18398829439 |
Associated GPIs | |
GCN Sequence Number | 082810 |
GCN Sequence Number Description | simethicone SYRINGE 20MG/0.3ML ORAL |
HIC3 | D4N |
HIC3 Description | ANTIFLATULENTS |
GCN | 51467 |
HICL Sequence Number | 001224 |
HICL Sequence Number Description | SIMETHICONE |
Brand/Generic | Generic |
Proprietary Name | MYLICON |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Simethicone |
Product Type | HUMAN OTC DRUG |
Dosage Form | SUSPENSION |
Route | ORAL |
Active Ingredient Strength | 20 |
Active Ingredient Units | mg/.3mL |
Substance Name | DIMETHICONE |
Labeler Name | ATLANTIC BIOLOGICALS CORP. |
Pharmaceutical Class | Skin Barrier Activity [PE] |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | part332 |
Listing Certified Through | 2024-12-31 |
Package
NDC 17856-0799-05 (17856079905)
NDC Package Code | 17856-0799-5 |
---|---|
Billing NDC | 17856079905 |
Package | 60 SYRINGE in 1 BOX, UNIT-DOSE (17856-0799-5) / 1.2 mL in 1 SYRINGE |
Marketing Start Date | 2023-04-06 |
NDC Exclude Flag | N |
Pricing Information | N/A |